Blood pressure control in haemodialysis patients: An audit

Nephrology

Volumn 11, Issue 2, 2006, Pages 100-104

  Al Hilali, Nabieh ^a,b   Al Humoud, Hani ^a   Ninan, Vadakethu T ^a   Nampoory, Mangalathillam R N ^a   Johny, Kaivilayil V ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Kuwait University ^*  (Kuwait)

Author keywords

Audit; Dry weight; Hemodialysis; Hypertension; Kt V

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; DRY WEIGHT; FEMALE; FLUID INTAKE; HEMODIALYSIS; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL CARE; MEDICAL RECORD; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; SALT INTAKE; STATISTICAL SIGNIFICANCE; WATER DEPRIVATION;

ANTIHYPERTENSIVE AGENTS; BODY WEIGHT; DIALYSIS SOLUTIONS; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MEDICAL AUDIT; MIDDLE AGED; RENAL DIALYSIS;

EID: 33645885344     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00549.x     Document Type: Article

References (29)

1. Sytkowski PA D'Agostino RB Belanger AI Kannel WE. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality: The Framingham heart study 1950-1990. Circulation 1996 93 697 703.
2. Burt VL Whelton P Roccella EJ et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination survey, 1988-1991. Hypertension 1995 25 305 13.
3. Raine A Margreiter R Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol. Dial. Transplant. 1992 2 S7 35.
4. Salem MM. Hypertension in hemodialysis population: A survey of 649 patients. Am. J. Kidney Dis. 1995 26 461 8.
5. Foley RN Parfrey PS Harnett JD Kent GM Murray DC Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996 49 1379 85.
6. Fernandez JM Carbonell ME Mazzuchi N Petruccelli D. Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients. Kidney Int. 1992 41 1029 34.
7. Iseki K Fukiyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int. 1996 50 1672 5.
8. Mazzuchi N Carbonell E Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient's survival. Kidney Int. 2000 38 2147 54.
9. Buckalew VM Jr Berg RL Wang SR Porush JG Rauch S Schulman G. Prevalence of hypertension in 1795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am. J. Kidney Dis. 1996 28 811 21.
10. Ozkahya M Ok E Cirit M et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol. Dial. Transplant. 1998 13 1489 93.
11. Charra B Calemard E Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am. J. Nephrol. 1996 16 35 44.
12. Krautzig S Janssen U Koch KM Granolleras C Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol. Dial. Transplant. 1998 13 552 3.
13. Wolcott DL Maida CA Diamond R Nissenson AR. Treatment compliance in end-stage renal disease patients on dialysis. Am. J. Nephrol. 1986 6 329 38.
14. Goldsmith DJ Covic AC Venning MC Ackrill P. Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am. J. Kidney Dis. 1997 29 593 600.
15. Feehally J Goldsmith D Ansell D et al. Chapter 11: Factors that may influence cardiovascular disease - Blood pressure and serum cholesterol. In The UK Renal Registry Report 2003. 2003 1 28.
16. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am. J. Kidney Dis. 2004 43 S1 11 13.
17. National Kidney Foundation. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. Am. J. Kidney Dis. 1997 30 S15 66 S67 136.
18. Crombie IK Davies HTO Abraham SCS Florey CduV. The Audit Handbook. Chichester John Willey and Sons 1993.
19. Converse RL Jr Jacobsen TN Toto RD et al. Sympathetic overactivity in patients with chronic renal failure. N. Engl. J. Med. 1992 31 1912 18.
20. Amann K Ritz E. Cardiovascular abnormalities in ageing and in uremia-only analogy or shared pathomechanisms? Nephrol. Dial. Transplant. 1998 13 S7 6 11.
21. Roger SD Grasty MS Baker LR Raine AE. Effects of oxygen breathing and erythropoietin on hypoxic vasodilatation in uremic anemia. Kidney Int. 1992 42 975 80.
22. Fliser D Franek E Fode P et al. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol. Dial. Transplant. 1997 12 933 8.
23. Marone C Beretta-Piccoli C Weidmann P. Acute hypercalcemic hypertension in man: Role of hemodynamics, catecholamines and renin. Kidney Int. 1981 20 92 6.
24. Argiles A Mourad G Mion C. Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis. N. Engl. J. Med. 1998 339 1364 70.
25. Ritz E Schwenger V Zeier M Rychlik I. Ambulatory blood pressure monitoring: Fancy gadgetry or clinically useful exercise? Nephrol. Dial. Transplant. 2001 6 1550 54.
26. Sherman RA Daniel A Cody RP. The effect of interdialytic weight gain on predialysis blood pressure. Artif. Organs 1993 17 770 74.
27. Dhakal MP Sloand JA Schiff MJ. Prevalence of hypertension and blood pressure control in hemodialysis patients. Dial. Transplant. 2000 29 628 37.
28. Abraham PA Opsahl JA Keshaviah PR et al. Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. Am. J. Kidney Dis. 1990 16 438 46.
29. Eknoyan G Beck GJ Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 2002 347 2010 19.